Evolus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. 

CEO
David Moatazedi
CEODavid Moatazedi
Employees
334
Employees334
Headquarters
Newport Beach, California
HeadquartersNewport Beach, California
Founded
2012
Founded2012
Employees
334
Employees334

EOLS Key Statistics

Market cap
368.89M
Market cap368.89M
Price-Earnings ratio
-7.05
Price-Earnings ratio-7.05
Dividend yield
Dividend yield
Average volume
2.09M
Average volume2.09M
High today
High today
Low today
Low today
Open price
$5.57
Open price$5.57
Volume
0.00
Volume0.00
52 Week high
$14.28
52 Week high$14.28
52 Week low
$4.09
52 Week low$4.09

Stock Snapshot

Evolus(EOLS) stock is priced at $5.64, giving the company a market capitalization of 368.89M. It carries a P/E multiple of -7.05.

On 2026-03-06, Evolus(EOLS) stock opened at $5.57, reached a high of —, and a low of —.

The Evolus(EOLS)'s current trading volume is 0, compared to an average daily volume of 2.09M.

During the past year, Evolus(EOLS) stock moved between $4.09 at its lowest and $14.28 at its peak.

During the past year, Evolus(EOLS) stock moved between $4.09 at its lowest and $14.28 at its peak.

EOLS News

TipRanks 1d
Data Privacy Compliance Risks Threaten Evolus’s Operations and Financial Health

Evolus, Inc. (EOLS) has disclosed a new risk, in the Environmental / Social category. Evolus, Inc. faces significant risk if it fails to comply with complex an...

Nasdaq 1d
Why Evolus Stock Soared Today

Key Points Demand for Evolus' beauty products is growing. Management expects to generate sustainable profits in 2026. 10 stocks we like better than Evolus ›...

Why Evolus Stock Soared Today
Nasdaq 3d
Evolus Q4 2025 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Evolus Q4 2025 Earnings Call Transcript

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More EOLS News

TipRanks 3d
Evolus Secures New Credit Facility and Reports Profitability

An announcement from Evolus ( (EOLS) ) is now available. On March 3, 2026, Evolus secured a new senior secured asset-based revolving credit facility of up to $...

TipRanks 3d
Evolus reports Q4 EPS 0c, consensus 4c

Reports Q4 revevnuee $90.3M, consensus $89.58M. “In 2025 we generated nearly $300 million in total net revenue delivering our sixth consecutive year of double-d...

People also own

Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.